Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 8.49
-0.21 (-2.47%)
At close: Mar 13, 2026
Genfit Market Cap
Genfit has a market cap or net worth of €422.76 million as of March 13, 2026. Its market cap has increased by 149.36% in one year.
Market Cap
422.76M
Enterprise Value
454.16M
Revenue
45.13M
Ranking
n/a
PE Ratio
n/a
Stock Price
€8.49
Market Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 422.76M, an increase of 189.43%. That is a compound annual growth rate of 5.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 422.76M | 61.25% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nanobiotix | 1.40B |
| DBV Technologies | 1.08B |
| Inventiva | 1.06B |
| Valneva SE | 831.23M |
| MedinCell | 792.04M |
| Cellectis | 243.74M |
| Transgene | 217.97M |
| Sensorion | 165.19M |